Food and Drug Administration
-
Alcobra's ADHD Drug Failed Phase III Trial
By Christie Abagon -
Low Calorie Sweeteners Being Used By More Kids
By Rodney Rafols -
FDA Approves Spinraza For Spinal Muscular Atrophy Treatment
By Christie Abagon -
Breakthrough Multiple Sclerosis Drug, Ocrelizumab, Slows Down Brain Damage
By Christie Abagon -
FDA Bans The Use Of Powdered Medical Gloves
By Kristen Hortaleza -
-
FDA Approves Ecstasy Clinical Trial To Treat PTSD
By Christie Abagon -
Rheumatoid Arteritis Medication, Actemra, Shows Positive Results
By Christie Abagon -
Botulinum Toxin: Nurse Pleads Guilty To Illegally Distributing Botox
By Rodney Rafols -
FDA Says Xarelto Safe Despite Controversy
By Rodney Rafols -
Novartis Ilaris Drug Now Allowed To Treat Childhood Arthritis By FDA
By Sridhar Nadamuni -
FDA Warns Migraine Treatment Drug Linked To Pregnancy Risk
By Hilda Scott -
-
More from iTechPost
-
DropBox Reports Hackers Stole Users' Emails, E-Signature in Latest Data Breach
-
UnitedHealth Cyberattack Could Have Affected One-Third of Americans, CEO Claims
-
TikTok Widely Seen as Chinese Influence Medium by Most Americans, Poll Reveals
-
'Bitcoin Jesus' Arrested for $48 Million Tax Evasion, Mail Fraud